Amgen vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?
One offers a more affordable entry point while the other boasts some of the highest profit margins in the sector. The choice comes down to whether you...
Last updated: 2026-10-06 12:14:08 ET
One offers a more affordable entry point while the other boasts some of the highest profit margins in the sector. The choice comes down to whether you...
Plus, Turner delivers a $29 million substance use treatment center, CMAA names a new CEO and a British engineering firm crosses the pond.
The practice of editing the genes of embryos remains highly controversial and risky, but Origin Genomics founder Cathy Tie argues its a “moral imper...
Analyst Geoff Meacham downgraded the biotech name to sell.
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE